Search research articles
Contact Us
Filters
Showing results (261-270 of 323) with videos related to
Page
of 33
Sort By:
Biomedicines
|
January 21, 2022
Drug Resistance in Glioma Cells Induced by a Mesenchymal-Amoeboid Migratory Switch
Sophie E Ketchen, Filomena O Gamboa-Esteves, Sean E Lawler, et al.
Kidney International Reports
|
February 3, 2026
A FIDELITY Analysis on Finerenone With SGLT-2i and GLP-1RA in CKD
Ajay K Singh, Stefan D Anker, Bertram Pitt, et al.
Diabetes, Obesity & Metabolism
|
June 28, 2018
Efficacy and safety of dapagliflozin or dapagliflozin plus saxagliptin versus glimepiride as add-on to metformin in patients with type 2 diabetes
Dirk Müller-Wieland, Monika Kellerer, Katarzyna Cypryk, et al.
American Journal of Nephrology
|
March 31, 2026
Effect of finerenone treatment discontinuation on kidney and cardiovascular outcomes: a FIDELITY analysis
Ajay K Singh, Stefan D Anker, Bertram Pitt, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
June 27, 2020
Identification of Dopaminergic Neurons That Can Both Establish Associative Memory and Acutely Terminate Its Behavioral Expression
Michael Schleyer, Aliće Weiglein, Juliane Thoener, et al.
American Journal of Preventive Cardiology
|
July 6, 2026
Impact of air pollution exposure on chronic kidney disease and type 2 diabetes: A FIDELITY analysis
Sadeer Al-Kindi, Zhuo Chen, Jean-Eudes Dazard, et al.
Haematologica
|
November 9, 2019
Src family kinase-mediated vesicle trafficking is critical for neutrophil basement membrane penetration
Ina Rohwedder, Angela R M Kurz, Monika Pruenster, et al.
Elife
|
December 19, 2024
Cytosolic S100A8/A9 promotes Ca<sup>2+</sup> supply at LFA-1 adhesion clusters during neutrophil recruitment
Matteo Napoli, Roland Immler, Ina Rohwedder, et al.
European Heart Journal
|
April 22, 2025
Incident hyperkalaemia risk model in chronic kidney disease and diabetes: the FIDELITY programme
João Pedro Ferreira, Stefan D Anker, Biff F Palmer, et al.
Annals of Internal Medicine
|
December 4, 2023
Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes : A Mediation Analysis
Rajiv Agarwal, Wanzhu Tu, Alfredo E Farjat, et al.
Page
of 33
Search research articles
Search
Showing results (261-270 of 323) with videos related to
Sort By:
Page
of 33
Biomedicines
|
January 21, 2022
Drug Resistance in Glioma Cells Induced by a Mesenchymal-Amoeboid Migratory Switch
Sophie E Ketchen, Filomena O Gamboa-Esteves, Sean E Lawler, et al.
Kidney International Reports
|
February 3, 2026
A FIDELITY Analysis on Finerenone With SGLT-2i and GLP-1RA in CKD
Ajay K Singh, Stefan D Anker, Bertram Pitt, et al.
Diabetes, Obesity & Metabolism
|
June 28, 2018
Efficacy and safety of dapagliflozin or dapagliflozin plus saxagliptin versus glimepiride as add-on to metformin in patients with type 2 diabetes
Dirk Müller-Wieland, Monika Kellerer, Katarzyna Cypryk, et al.
American Journal of Nephrology
|
March 31, 2026
Effect of finerenone treatment discontinuation on kidney and cardiovascular outcomes: a FIDELITY analysis
Ajay K Singh, Stefan D Anker, Bertram Pitt, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
June 27, 2020
Identification of Dopaminergic Neurons That Can Both Establish Associative Memory and Acutely Terminate Its Behavioral Expression
Michael Schleyer, Aliće Weiglein, Juliane Thoener, et al.
American Journal of Preventive Cardiology
|
July 6, 2026
Impact of air pollution exposure on chronic kidney disease and type 2 diabetes: A FIDELITY analysis
Sadeer Al-Kindi, Zhuo Chen, Jean-Eudes Dazard, et al.
Haematologica
|
November 9, 2019
Src family kinase-mediated vesicle trafficking is critical for neutrophil basement membrane penetration
Ina Rohwedder, Angela R M Kurz, Monika Pruenster, et al.
Elife
|
December 19, 2024
Cytosolic S100A8/A9 promotes Ca<sup>2+</sup> supply at LFA-1 adhesion clusters during neutrophil recruitment
Matteo Napoli, Roland Immler, Ina Rohwedder, et al.
European Heart Journal
|
April 22, 2025
Incident hyperkalaemia risk model in chronic kidney disease and diabetes: the FIDELITY programme
João Pedro Ferreira, Stefan D Anker, Biff F Palmer, et al.
Annals of Internal Medicine
|
December 4, 2023
Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes : A Mediation Analysis
Rajiv Agarwal, Wanzhu Tu, Alfredo E Farjat, et al.
Page
of 33